drugset / Trial / NCT03878771
PRF in Management of Chronic Multiple Oral Ulcers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
PRF in orabase will be applied as a pack material on chronic oral ulcers of chronic multiple oral lesions compared to conventional topical steroid therapy with clobetasol propionate 0.05% in orabase. The outcomes measured are Pain alleviation as Primary outcome and Clinical improvement in terms of Ulcer size, Number and Mucositis score as Secondary outcomes. Time frame for outcomes assessment will be Daily for 7 Days regarding pain score and weekly for 2 weeks regarding clinical improvement.
Timeline
- Start
- 2019-03-13
- Primary completion
- 2019-04-15
- Completion
- 2019-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Concentrate | Other / unclassified | — | Topical |
| Comparator | clobetasol propionate | Small molecule | 0.05 % | Topical |